Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1145938 | 0.85 | ALDH1A1 (0.54) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL27527331 | 0.85 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL3405892 | 0.84 | ALDH1A1 (0.48) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL1727075 | 0.81 | ALDH1A1 (0.48) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL7841404 | 0.80 | PDE1B (0.39) | POLBMEN1KMT2ALMNAGAA | |
| SCHEMBL2644223 | 0.79 | GABRP (0.43) | KDM4E | |
| SCHEMBL12509022 | 0.77 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL21348435 | 0.75 | PDE2A (0.37) | — | |
| SCHEMBL31508111 | 0.74 | ALDH1A1 (0.45) | ALDH1A1NPC1RAB9APOLBMAPT | |
| SCHEMBL795938 | 0.74 | ALDH1A1 (0.46) | ALDH1A1NPC1RAB9APOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102762206-A | Homogeneous suspension of immunopotentiating compounds and uses thereof | NOVARTIS AG | 2012-10-31 | — | — | CN | disclosed |